APA (7th ed.) Citation

Karg, M. V., Bosch, A., Kannenkeril, D., Striepe, K., Ott, C., Schneider, M. P., . . . Schmieder, R. E. (2018). SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: A randomised controlled trial. Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU).

Chicago Style (17th ed.) Citation

Karg, M. V., et al. SGLT-2-inhibition with Dapagliflozin Reduces Tissue Sodium Content: A Randomised Controlled Trial. Erlangen: Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2018.

MLA (9th ed.) Citation

Karg, M. V., et al. SGLT-2-inhibition with Dapagliflozin Reduces Tissue Sodium Content: A Randomised Controlled Trial. Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2018.